Nurix Therapeutics Inc (NRIX)

SBC to Revenue

1.60%

Quarterly · Period ending:

NRIX logo

NRIX SBC to Revenue

Latest reported1.60%
NRIX Quarterly SBC/Revenue (1.10% → 1.60%)
High-resolution chart · PNG

NRIX sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
1.6012%
125.9317%
150.4159%
66.922%
123.7902%
23.5723%
47.266%
64.047%
69.5424%
73.1475%
47.1631%
52.9323%
45.7302%
28.4359%
66.8585%
122.3205%
64.7577%
59.2635%
63.1015%
65.4813%
42.0698%
55.6198%
53.8815%
37.913%
27.295%
11.3343%
6.1453%
8.9689%
1.2854%
1.1124%
1.1046%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.